Literature DB >> 19849826

Severe community acquired pneumonia: what should we predict?

Bertrand Renaud, Aline Santin.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19849826      PMCID: PMC2784381          DOI: 10.1186/cc8111

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.

Several aspects relating to the definition of severe community acquired pneumonia (CAP) and the design of prediction tools need to be addressed prior to further attempts to predict severe CAP. What is the concept of severe CAP based on? CAP severity could be based on pathophysiological disorders that would allow physicians to objectively define severity. Alternatively, CAP severity could be based on treatment intensity, which would certainly facilitate its uptake and the development of clinical tools to assist physicians in decision-making. This second approach, which seems more clinically relevant, will be assumed for the rest of this letter. What are the most relevant criteria for severe CAP? Basically, there are two possibilities: admission to ICU or respiratory/circulatory support requirement [1]. The former criterion is often perceived as too vague as it remains a matter of individual judgment [2]. The second is less prone to subjectivity, but may be too restrictive, as intensive care benefit is not limited to patients that require vital support. However, one must keep in mind the final objective of developing prediction tools for severe CAP; in this context, the definition exclusively based on respiratory/hemodynamic support requirement is less restrictive. Therefore, consistent with Chalmers [3], we suggest keeping this second definition of CAP severity. At this point, several features regarding prediction of severe CAP may be considered. Given the increasing evidence that patients with incipient severe sepsis may benefit from intensive care and from early referral, this prediction would apply to CAP patients presenting to the emergency department with rapidly progressive pneumonia at high risk of developing organ failure but with no overt respiratory/hemodynamic distress [4]. Indeed, predicting what is obvious is of no value. In contrast, patients that are too sick to be eligible for ICU admission have to be excluded. Additionally, regardless of the 30-day risk of severe CAP after presentation to the emergency department, if the 7-day risk is extremely low, CAP patients could be hospitalized in the wards. By contrast, if the 7-day risk is high, physicians would likely want to provide intensive care. Therefore, the most effective prediction tool would ascertain the risk of severe CAP within a week of presentation and assist physicians in making the critical ICU admission decision [5]. It is time for the medical community to unequivocally define severe CAP with the aim of improving the efficiency of resource utilization and the effectiveness of management strategies for patients that present with moderately severe CAP.

Abbreviations

CAP: community acquired pneumonia.

Competing interests

The authors declare that they have no competing interests.
  5 in total

1.  Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Authors:  E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Admissions to intensive care units from emergency departments: a descriptive study.

Authors:  H K Simpson; M Clancy; C Goldfrad; K Rowan
Journal:  Emerg Med J       Date:  2005-06       Impact factor: 2.740

3.  ICU admission and severity assessment in community-acquired pneumonia.

Authors:  James D Chalmers
Journal:  Crit Care       Date:  2009-06-15       Impact factor: 9.097

4.  SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia.

Authors:  Patrick G P Charles; Rory Wolfe; Michael Whitby; Michael J Fine; Andrew J Fuller; Robert Stirling; Alistair A Wright; Julio A Ramirez; Keryn J Christiansen; Grant W Waterer; Robert J Pierce; John G Armstrong; Tony M Korman; Peter Holmes; D Scott Obrosky; Paula Peyrani; Barbara Johnson; Michelle Hooy; M Lindsay Grayson
Journal:  Clin Infect Dis       Date:  2008-08-01       Impact factor: 9.079

5.  Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule.

Authors:  Bertrand Renaud; José Labarère; Eva Coma; Aline Santin; Jan Hayon; Mercé Gurgui; Nicolas Camus; Eric Roupie; François Hémery; Jérôme Hervé; Mirna Salloum; Michael J Fine; Christian Brun-Buisson
Journal:  Crit Care       Date:  2009-04-09       Impact factor: 9.097

  5 in total
  1 in total

1.  Procalcitonin as an Early Marker of the Need for Invasive Respiratory or Vasopressor Support in Adults With Community-Acquired Pneumonia.

Authors:  Wesley H Self; Carlos G Grijalva; Derek J Williams; Alison Woodworth; Robert A Balk; Sherene Fakhran; Yuwei Zhu; D Mark Courtney; James Chappell; Evan J Anderson; Chao Qi; Grant W Waterer; Christopher Trabue; Anna M Bramley; Seema Jain; Kathryn M Edwards; Richard G Wunderink
Journal:  Chest       Date:  2016-04-21       Impact factor: 9.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.